rs144691638
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2
The NM_001165963.4(SCN1A):c.5568G>A(p.Met1856Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000725 in 1,613,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.5568G>A | p.Met1856Ile | missense_variant | Exon 29 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.5568G>A | p.Met1856Ile | missense_variant | Exon 28 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.5535G>A | p.Met1845Ile | missense_variant | Exon 26 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.5484G>A | p.Met1828Ile | missense_variant | Exon 26 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes AF: 0.000349 AC: 53AN: 152006Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250732Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135470
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461752Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727192
GnomAD4 genome AF: 0.000348 AC: 53AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.000323 AC XY: 24AN XY: 74366
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
- -
not specified Benign:1
Variant summary: SCN1A c.5568G>A (p.Met1856Ile) results in a conservative amino acid change in the encoded protein sequence. Two of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 250732 control chromosomes, predominantly at a frequency of 0.0014 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 78 fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN1A causing SCN1A-Related Seizure Disorder phenotype (1.8e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.5568G>A in individuals affected with SCN1A-Related Seizure Disorder and no experimental evidence demonstrating its impact on protein function have been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classifed the variant as VUS (n=1) and benign/likely benign (n=3). Based on the evidence outlined above, the variant was classified as likely benign. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Early infantile epileptic encephalopathy with suppression bursts Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at